Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2525 of 3173 entries
View as:

Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study

Phase: N/A Priority: Normal
NCT ID: NCT02454530 Org: User:
Start: 09/30/14 End: 01/31/17 Due: 01/31/18

Crizotinib Continuation Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT05160922 Org: User:
Start: 12/27/21 End: 03/21/28 Due: 03/21/29

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00277810 Org: User:
Start: 03/31/06 End: 06/30/08 Due: 06/30/09

Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.

Phase: N/A Priority: Normal
NCT ID: NCT00479570 Org: User:
Start: 06/30/07 End: 02/29/08 Due: 02/28/09

A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01821066 Org: User:
Start: 04/30/13 End: 08/31/13 Due: 08/31/14

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01470612 Org: User:
Start: 10/01/12 End: 08/06/20 Due: 08/06/21

Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01166555 Org: User:
Start: 05/31/10 End: 10/31/10 Due: 10/31/11

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Phase: N/A Priority: Normal
NCT ID: NCT00227188 Org: User:
Start: 05/31/03 End: 12/31/05 Due: 12/31/06

A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01981499 Org: User:
Start: 01/31/14 End: 04/30/14 Due: 04/30/15

Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US

Phase: N/A Priority: Normal
NCT ID: NCT05260684 Org: User:
Start: 01/17/22 End: 12/31/23 Due: 12/31/24

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03864042 Org: User:
Start: 01/02/18 End: 05/29/23 Due: 05/29/24

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00094094 Org: User:
Start: 02/28/05 End: 07/31/07 Due: 07/31/08

A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01562899 Org: User:
Start: 08/27/12 End: 04/01/15 Due: 04/01/16

Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT01445873 Org: User:
Start: 12/01/09 End: 03/28/11 Due: 03/28/12

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04624230 Org: User:
Start: 08/12/21 End: 05/15/29 Due: 05/15/30

Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01374139 Org: User:
Start: 08/31/11 End: 10/31/11 Due: 10/31/12

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT05145127 Org: User:
Start: 11/17/21 End: 07/31/30 Due: 07/31/31

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT00689273 Org: User:
Start: 08/05/08 End: 11/27/08 Due: 11/27/09

Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234

Phase: N/A Priority: Normal
NCT ID: NCT02711462 Org: User:
Start: 02/29/16 End: 08/31/16 Due: 08/31/17

A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT03536390 Org: User:
Start: 09/19/18 End: 04/22/21 Due: 04/22/22

A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00769067 Org: User:
Start: 11/30/08 End: 08/31/14 Due: 08/31/15

A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00090701 Org: User:
Start: 09/30/04 End: - Due: -

Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00425061 Org: User:
Start: 02/28/07 End: 08/31/08 Due: 08/31/09

A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03963401 Org: User:
Start: 06/13/19 End: 01/15/21 Due: 01/15/22

A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031

Phase: N/A Priority: Normal
NCT ID: NCT00814736 Org: User:
Start: 08/31/08 End: 09/30/08 Due: 09/30/09